Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
Kymera Therapeutics (KYMR) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.18 B
According to Kymera Therapeutics's latest financial reports the company's total liabilities are $0.18 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Kymera Therapeutics - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.18 B | 60.01% |
| 2022-12-31 | $0.11 B | -22.76% |
| 2021-12-31 | $0.14 B | -28.05% |
| 2020-12-31 | $0.20 B | 6.37% |
| 2019-12-31 | $0.19 B | 142.93% |
| 2018-12-31 | $78.66 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -84.56% | 🇺🇸 USA |